SMTL ID : 5j13.1

Structural basis for TSLP antagonism by the therapeutic antibody Tezepelumab (MEDI9929 / AMG-157)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-1-mer

Ligands

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 6 residues within 4Å: Chain B: E.113, K.135, T.137, Y.173, K.199, Y.205 8 PLIP interactions: 8 interactions with chain B Hydrogen bonds: B:Y.173, B:Y.173, B:Y.205, B:Y.205 Water bridges: B:K.135, B:Q.141, B:Q.141 Salt bridges: B:K.199 SO4.2: 4 residues within 4Å: Chain B: A.160, K.162 Chain C: S.160, F.162 5 PLIP interactions: 1 interactions with chain C, 4 interactions with chain B Hydrogen bonds: C:S.160 Water bridges: B:K.162, B:K.162, B:K.162 Salt bridges: B:K.162 SO4.3: 4 residues within 4Å: Chain B: Q.200, S.201 Chain C: H.204, T.205 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain C Hydrogen bonds: B:S.201, B:S.201 Water bridges: B:N.202 Salt bridges: C:H.204

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Verstraete, K. et al., Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma. Nat Commun (2017)

Release Date

2017-04-05

Peptides

Thymic stromal lymphopoietin: A
anti-TSLP Fab-fragment, light chain: B
anti-TSLP Fab-fragment, heavy chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Thymic stromal lymphopoietin

anti-TSLP Fab-fragment, light chain

anti-TSLP Fab-fragment, heavy chain

Related Entries With Identical Sequence